The reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.58BCNY
297.53M · vs all stocks (USD)
Updated Nov 22, 2026
Trailing P/E
170.67x
vs Medical Instruments & Supplies peers
Updated Nov 22, 2026
Revenue (TTM)
500.48MCNY
70.51M · vs all stocks (USD)
Updated Nov 22, 2026
Profit Margin
1.87%
vs Medical Instruments & Supplies peers
Updated Nov 22, 2026
Beta
0.5060x
vs all stocks
Updated Nov 22, 2026
52-Week Change
-35.19%
vs all stocks
Updated Nov 22, 2026
Market Capitalization
1.58BCNY
297.53M · vs all stocks (USD)
Updated Nov 22, 2026
Enterprise Value
1.54BCNY
295.28M · vs all stocks (USD)
Updated Nov 22, 2026
Trailing P/E
170.67x
vs Medical Instruments & Supplies peers
Updated Nov 22, 2026
Forward P/E
23.27x
vs Medical Instruments & Supplies peers
Updated Nov 22, 2026
Price to Sales (TTM)
3.16x
vs Medical Instruments & Supplies peers
Updated Nov 22, 2026
Price to Book (MRQ)
2.48x
vs Medical Instruments & Supplies peers
Updated Nov 22, 2026
Enterprise to Revenue
3.07x
vs Medical Instruments & Supplies peers
Updated Nov 22, 2026
Enterprise to EBITDA
21.00x
vs Medical Instruments & Supplies peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 15.54×.Updated Nov 22, 2026
Gross Margin
45.39%
vs Medical Instruments & Supplies peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 41.55%.Updated Nov 22, 2026
Profit Margin
1.87%
vs Medical Instruments & Supplies peers
Updated Nov 22, 2026
Operating Margin
9.04%
vs Medical Instruments & Supplies peers
Updated Nov 22, 2026
Return on Assets (TTM)
2.81%
vs Medical Instruments & Supplies peers
Updated Nov 22, 2026
Return on Equity (TTM)
1.75%
vs Medical Instruments & Supplies peers
Updated Nov 22, 2026
Revenue (TTM)
500.48MCNY
70.51M · vs all stocks (USD)
Updated Nov 22, 2026
Revenue per Share (TTM)
1.66CNYUpdated Nov 22, 2026
Quarterly Revenue Growth
25.40%
vs Medical Instruments & Supplies peers
Updated Nov 22, 2026
Gross Profit (TTM)
207.94MCNY
30.61M · vs all stocks (USD)
Updated Nov 22, 2026
EBITDA (TTM)
98.82MCNY
14.81M · vs all stocks (USD)
Updated Nov 22, 2026
Net Income (TTM)
9.35MCNY
4.51M · vs all stocks (USD)
Updated Nov 22, 2026
Operating Cash Flow (TTM)
112.24MCNY
22.42M · vs all stocks (USD)
Updated Nov 22, 2026
Levered Free Cash Flow (TTM)
101.37MCNY
16.28M · vs all stocks (USD)
Updated Nov 22, 2026
5-Year Average Dividend Yield
0.20%
vs all stocks
Updated Nov 22, 2026
Payout Ratio
0.00%
vs Medical Instruments & Supplies peers
Updated Nov 22, 2026
Minority Interest (Equity)
34.76MCNYFY2025 · Dec 31, 2025
Revenue
486.26MCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
277.14MCNYFY2025 · Dec 31, 2025
Gross Profit
209.12MCNYFY2025 · Dec 31, 2025
Operating Income
41.85MCNY
6.27M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
22.72MCNYFY2025 · Dec 31, 2025
Income Tax Expense
7.50MCNYFY2025 · Dec 31, 2025
Net Income
15.21MCNYFY2025 · Dec 31, 2025
EBIT
27.86MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
98.82MCNYFY2025 · Dec 31, 2025
Research & Development
23.65MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
49.91MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
7.05MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
1.09MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
5.14MCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.0500CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.0500CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
290.61MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
290.61MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
15.21MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
-683.83KCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
177.41MCNYFY2025 · Dec 31, 2025
Free Cash Flow
154.86MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
159.20MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
15.21MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
7.61MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
141.92MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
12.65MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-22.55MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-10.00MCNYFY2025 · Dec 31, 2025
Sale of Investments
37.52MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
4.98MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
231.40MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-423.07MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-5.50MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-3.10MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-200.27MCNYFY2025 · Dec 31, 2025
Shares Outstanding
309.19MSharesUpdated Nov 22, 2026
Float Shares
208.87MSharesUpdated Nov 22, 2026
% Held by Insiders
37.35%
vs all stocks
Updated Nov 22, 2026
% Held by Institutions
3.60%
vs all stocks
Updated Nov 22, 2026
Total Cash (MRQ)
137.10MCNY
22.46M · vs all stocks (USD)
Updated Nov 22, 2026
Total Cash per Share (MRQ)
0.4430CNYUpdated Nov 22, 2026
Total Debt (MRQ)
60.30MCNY
15.00M · vs all stocks (USD)
Updated Nov 22, 2026
Total Debt to Equity (MRQ)
0.0902x
vs Medical Instruments & Supplies peers
Updated Nov 22, 2026
Current Ratio (MRQ)
1.60x
vs Medical Instruments & Supplies peers
Updated Nov 22, 2026
Book Value per Share (MRQ)
2.07CNYUpdated Nov 22, 2026
Total Assets
1.03BCNY
153.93M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
423.34MCNYFY2025 · Dec 31, 2025
Total Liabilities
371.82MCNYFY2025 · Dec 31, 2025
Total Non-current Assets
603.58MCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
53.95MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
317.87MCNYFY2025 · Dec 31, 2025
Cash
159.22MCNYFY2025 · Dec 31, 2025
Cash Equivalents
1.09MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
160.32MCNYFY2025 · Dec 31, 2025
Accounts Receivable
124.26MCNYFY2025 · Dec 31, 2025
Inventory
81.15MCNYFY2025 · Dec 31, 2025
Accounts Payable
70.58MCNYFY2025 · Dec 31, 2025
Short-term Debt
129.03MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
2.14MCNYFY2025 · Dec 31, 2025
Long-term Debt
24.69MCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
5.28MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
309.19MCNYFY2025 · Dec 31, 2025
Retained Earnings
-136.74MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
655.10MCNY
98.19M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
5.07CNYUpdated Nov 22, 2026
52-Week High
9.00CNYUpdated Nov 22, 2026
52-Week Change
-35.19%
vs all stocks
Updated Nov 22, 2026
Beta
0.5060x
vs all stocks
Updated Nov 22, 2026
50-Day MA
6.67CNYUpdated Nov 22, 2026
200-Day MA
7.12CNYUpdated Nov 22, 2026
Avg 10-Day Volume
34.87MSharesUpdated Nov 22, 2026
Avg 30-Day Volume
26.15MSharesUpdated Nov 22, 2026
Diluted EPS (TTM)
0.0300CNYUpdated Nov 22, 2026
3 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Rising Operating Income With Falling Gross Profit and Shrinking Assets
Operating income has risen while gross profit and the asset base both shrank.
Reads
Cash-Flow Ratios Elevated
More of its sales turn into cash than in its industry, and less of that cash is consumed by reinvestment than at most of its peers.
Reads
FCF Ratios Elevated
Its free cash flow is large next to assets and equity, and more of its operating cash reaches it than in its industry.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.45Profit Margin: 0.06
Financial Health
Altman Z-Score 3.7: safe zoneNotable
Altman Z-Score: 3.70
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Companies that share the same coordination system — how they create, deliver, or capture value.